IPHA Annual Cash & Cash Equivalents
$78.05 M
-$12.28 M-13.59%
31 December 2023
Summary:
As of January 23, 2025, IPHA annual cash & cash equivalents is $78.05 million, with the most recent change of -$12.28 million (-13.59%) on December 31, 2023. During the last 3 years, it has fallen by -$90.20 million (-53.61%). IPHA annual cash & cash equivalents is now -65.66% below its all-time high of $227.27 million, reached on December 31, 2019.IPHA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Quarterly Cash And Cash Equivalents
$75.02 M
-$3.02 M-3.88%
30 June 2024
Summary:
As of January 23, 2025, IPHA quarterly cash and cash equivalents is $75.02 million, with the most recent change of -$3.02 million (-3.88%) on June 30, 2024. Over the past year, it has dropped by -$2.59 million (-3.33%). IPHA quarterly cash and cash equivalents is now -75.66% below its all-time high of $308.18 million, reached on June 30, 2015.IPHA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | -3.3% |
| 3 y3 years | -53.6% | -3.3% |
| 5 y5 years | -55.2% | -3.3% |
IPHA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.6% | at low | -36.1% | at low |
| 5 y | 5-year | -65.7% | at low | -55.4% | at low |
| alltime | all time | -65.7% | +2450.2% | -75.7% | +153.0% |
Innate Pharma SA Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $75.02 M(-3.9%) |
| Dec 2023 | $78.05 M(-13.6%) | $78.05 M(+0.6%) |
| June 2023 | - | $77.61 M(-14.1%) |
| Dec 2022 | $90.32 M(-23.1%) | $90.32 M(-16.0%) |
| June 2022 | - | $107.54 M(-8.5%) |
| Dec 2021 | $117.47 M(-30.2%) | $117.47 M(-5.1%) |
| June 2021 | - | $123.74 M(-26.5%) |
| Dec 2020 | $168.25 M(-26.0%) | $168.25 M(+13.7%) |
| June 2020 | - | $147.94 M(-34.9%) |
| Dec 2019 | $227.27 M(+30.4%) | $227.27 M(+33.8%) |
| June 2019 | - | $169.84 M(-2.5%) |
| Dec 2018 | $174.23 M(+46.2%) | $174.23 M(+89.5%) |
| June 2018 | - | $91.92 M(-22.9%) |
| Dec 2017 | $119.21 M(-35.9%) | $119.21 M(-31.0%) |
| June 2017 | - | $172.74 M(-7.1%) |
| Dec 2016 | $185.96 M(+11.3%) | $185.96 M(+4.6%) |
| June 2016 | - | $177.81 M(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $167.13 M(+113.8%) | $167.13 M(-45.8%) |
| June 2015 | - | $308.18 M(+294.2%) |
| Dec 2014 | $78.17 M(+47.6%) | $78.17 M(-22.5%) |
| June 2014 | - | $100.92 M(+90.5%) |
| Dec 2013 | $52.97 M(+31.0%) | $52.97 M(+78.6%) |
| June 2013 | - | $29.65 M(-26.7%) |
| Dec 2012 | $40.45 M(-33.0%) | $40.45 M(-13.9%) |
| June 2012 | - | $46.95 M(-22.2%) |
| Dec 2011 | $60.37 M(+42.7%) | $60.37 M(+40.6%) |
| June 2011 | - | $42.93 M(+1.4%) |
| Dec 2010 | $42.32 M(-36.3%) | $42.32 M(-4.9%) |
| June 2010 | - | $44.50 M(-33.0%) |
| Dec 2009 | $66.42 M(+336.7%) | $66.42 M |
| Dec 2008 | $15.21 M(+319.9%) | - |
| Dec 2007 | $3.62 M(-55.4%) | - |
| Dec 2006 | $8.13 M(+165.5%) | - |
| Dec 2005 | $3.06 M | - |
FAQ
- What is Innate Pharma SA annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Innate Pharma SA?
- What is Innate Pharma SA annual cash & cash equivalents year-on-year change?
- What is Innate Pharma SA quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Innate Pharma SA?
- What is Innate Pharma SA quarterly cash and cash equivalents year-on-year change?
What is Innate Pharma SA annual cash & cash equivalents?
The current annual cash & cash equivalents of IPHA is $78.05 M
What is the all time high annual cash & cash equivalents for Innate Pharma SA?
Innate Pharma SA all-time high annual cash & cash equivalents is $227.27 M
What is Innate Pharma SA annual cash & cash equivalents year-on-year change?
Over the past year, IPHA annual cash & cash equivalents has changed by -$12.28 M (-13.59%)
What is Innate Pharma SA quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IPHA is $75.02 M
What is the all time high quarterly cash and cash equivalents for Innate Pharma SA?
Innate Pharma SA all-time high quarterly cash and cash equivalents is $308.18 M
What is Innate Pharma SA quarterly cash and cash equivalents year-on-year change?
Over the past year, IPHA quarterly cash and cash equivalents has changed by -$2.59 M (-3.33%)